Cargando…
Strategies to Prevent Anthracycline-Related Congestive Heart Failure in Survivors of Childhood Cancer
Cardiovascular complications are a leading cause of therapy-related morbidity and mortality in long-term survivors of childhood malignancy. In fact, childhood cancer survivors are at a 15-fold risk of developing CHF compared to age-matched controls. There is a strong dose-dependent association betwe...
Autores principales: | Armenian, Saro H., Gelehrter, Sarah K., Chow, Eric J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426199/ https://www.ncbi.nlm.nih.gov/pubmed/22928146 http://dx.doi.org/10.1155/2012/713294 |
Ejemplares similares
-
Rationale and design of the Children’s Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure
por: Armenian, Saro H., et al.
Publicado: (2016) -
Haptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A COG-ALTE03N1 Report
por: Singh, Purnima, et al.
Publicado: (2023) -
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
por: Bansal, Neha, et al.
Publicado: (2019) -
Atlas-based measures of left ventricular shape may improve characterization of adverse remodeling in anthracycline-exposed childhood cancer survivors: a cross-sectional imaging study
por: Narayan, Hari K., et al.
Publicado: (2020) -
REPLY: Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy
por: Aziz-Bose, Rahela, et al.
Publicado: (2023)